Christopher D. Byrne

Author

University of Southampton ORCID

Also Known As

Byrne, C, Byrne, C.D., Byrne, CD, C Byrne, C D Byrne, C. B. Byrne, C. Byrne, C. D Byrne, C. D. Byrne, C.D Byrne

826

Publications

47.1K

Citations

104

H-Index

242

Concepts

All Affiliations

University of Southampton University Hospital Southampton NHS Foundation Trust Southampton General Hospital National Institute for Health Research Azienda Ospedaliera Universitaria Integrata Verona

About

Christopher D. Byrne is an author at University of Southampton specializing in medicine, metabolic syndrome, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	44	95	8.3K
2	Health Sciences	32	59	6.1K
3	Engineering	4	4	99
4	Education	1	1	20
5	Management	1	1	163

Christopher D. Byrne

270

Publications

18.1K

Citations

H-Index

Page 1

	Year	Citations
A multisociety Delphi consensus statement on new fatty liver disease nomenclature Mary E. Rinella, Jeffrey V. Lazarus, Vlad Ratziu, Hepatology Evidence-based MedicinePathologyFatty Liver DiseaseObesityMetabolic Syndrome	2023	2.5K
Expression of Inducible Nitric Oxide Synthase in Human Heart Failure Guy A. Haywood, Philip S. Tsao, Heiko E. von der Leyen, Circulation	1996	493
Maternal high‐fat feeding primes steatohepatitis in adult mice offspring, involving mitochondrial dysfunction and altered lipogenesis gene expression† Kimberley D. Bruce, Felino R. Cagampang, Marco Argenton, Hepatology	2009	440
Depot-related gene expression in human subcutaneous and omental adipocytes. Johannes B. Prins, Laura Sanders, J Zhang, Diabetes Human Omental AdipocytesSc AdipocytesAdipokinesInsulin SignalingDepot-related Gene Expression	1998	332
MAFLD and risk of CKD Dan‐Qin Sun, Yan Jin, Ting-Yao Wang, Metabolism Preventive MedicineDisease Risk AssessmentMedicineRiskNon-communicable Disease	2020	307
Effects of purified eicosapentaenoic and docosahexaenoic acids in nonalcoholic fatty liver disease: Results from the WELCOME* study Eleonora Scorletti, Lokpal Bhatia, Keith McCormick, Hepatology PathologyEpa EnrichmentFatty Liver DiseaseObesityMetabolic Syndrome	2014	306
Global burden of metabolic diseases, 1990–2021 Huai Zhang, Xiaodong Zhou, Michael D. Shapiro, Metabolism ObesityMetabolic SyndromeGlobal BurdenEpidemiologyMetabolic Disorder	2024	240
Administrative Coding in Electronic Health Care Record‐Based Research of NAFLD: An Expert Panel Consensus Statement Hannes Hagström, Leon A. Adams, Alina M. Allen, Hepatology	2021	231
Maternal high fat diet during pregnancy and lactation alters hepatic expression of insulin like growth factor-2 and key microRNAs in the adult offspring Jun‐Long Zhang, Fang Zhang, Xavier Didelot, BMC Genomics	2009	217
Combined Influence of Insulin Resistance, Overweight/Obesity, and Fatty Liver as Risk Factors for Type 2 Diabetes Ki‐Chul Sung, Woo-Shin Jeong, Sarah H. Wild, Diabetes Care	2012	214

Page 1